Lydia C T Buer (Lydia Buer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Patients With Inflammatory Bowel Disease

Rheumatoid Arthritis Patients

Top Venues

Scandinavian journal of gastroenterology

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Thea H Wiken, Marte L Høivik, Karoline Anisdahl, Lydia C T Buer, David J Warren, Nils Bolstad, Milada Cvancarova Småstuen Hagen, Bjørn A Moum, Asle Wilhelm Medhus
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study. Crohn's & colitis 360 6 (1) (2024)
Thea H Wiken, Marte L Høivik, Karoline Anisdahl, Lydia C T Buer, David J Warren, Nils Bolstad, Milada Cvancarova Småstuen Hagen, Bjørn A Moum, Asle Wilhelm Medhus
Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study. Crohn's & colitis 360 6 (1) (2024)
Thea H Wiken, Marte Lie Høivik, Lydia C T Buer, David J Warren, Nils Bolstad, Bjørn A Moum, Karoline Anisdahl, Milada C Småstuen, Asle Wilhelm Medhus
Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring. Scandinavian journal of gastroenterology (2023)
Lydia C T Buer, Bjørn A Moum, Milada Cvancarova, David J Warren, Nils Bolstad, Asle W Medhus, Marte L Høivik
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort. Scandinavian journal of gastroenterology 54 (1) (2019)